Antifungals: use in high-risk patients

Advanced medical technology has resulted in a growing population of patients with altered defense mechanisms against nosocomial infections. Fungal infections, primarily Candida species, account for a significant proportion of hospital-acquired infections and are associated with increased morbidity and mortality. This article discusses current issues and controversies related to nosocomial fungal infections and summarizes optimal management strategies.